These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 1681898

  • 1. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D, Matsueda GR, Haber E, Reed GL.
    Biochemistry; 1991 Oct 22; 30(42):10164-70. PubMed ID: 1681898
    [Abstract] [Full Text] [Related]

  • 2. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM, Song Y, Sheng D, Ball EL, Matsueda GR.
    Thromb Haemost; 1995 Sep 22; 74(3):923-7. PubMed ID: 8571322
    [Abstract] [Full Text] [Related]

  • 3. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
    Souri M, Osaki T, Ichinose A.
    J Biol Chem; 2015 May 08; 290(19):12027-39. PubMed ID: 25809477
    [Abstract] [Full Text] [Related]

  • 4. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL, Lukacova D.
    Thromb Haemost; 1995 Aug 08; 74(2):680-5. PubMed ID: 8585006
    [Abstract] [Full Text] [Related]

  • 5. Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies.
    Osaki T, Magari Y, Souri M, Ichinose A.
    Monoclon Antib Immunodiagn Immunother; 2024 Oct 08; 43(5):135-143. PubMed ID: 39320988
    [Abstract] [Full Text] [Related]

  • 6. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
    Hettasch JM, Peoples KA, Greenberg CS.
    J Biol Chem; 1997 Oct 03; 272(40):25149-56. PubMed ID: 9312126
    [Abstract] [Full Text] [Related]

  • 7. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H, Anderson K, McPhedran P, Clyne L, McDonagh J.
    Blood; 1992 Jan 01; 79(1):65-74. PubMed ID: 1370210
    [Abstract] [Full Text] [Related]

  • 8. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ.
    Blood; 2000 Aug 01; 96(3):988-95. PubMed ID: 10910914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
    Protopopova AD, Ramirez A, Klinov DV, Litvinov RI, Weisel JW.
    J Thromb Haemost; 2019 May 01; 17(5):737-748. PubMed ID: 30773828
    [Abstract] [Full Text] [Related]

  • 11. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L, Adány R, Mikkola H.
    Crit Rev Clin Lab Sci; 1996 May 01; 33(5):357-421. PubMed ID: 8922891
    [Abstract] [Full Text] [Related]

  • 12. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.
    Souri M, Yokoyama C, Osaki T, Ichinose A.
    Thromb Haemost; 2023 Sep 01; 123(9):841-854. PubMed ID: 36934722
    [Abstract] [Full Text] [Related]

  • 13. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T, Sugiyama D, Magari Y, Souri M, Ichinose A.
    Thromb Haemost; 2015 Jun 01; 113(6):1347-56. PubMed ID: 25740658
    [Abstract] [Full Text] [Related]

  • 14. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC, Trumbo TA, Isetti G, Turner BT.
    Arch Biochem Biophys; 2006 Jan 01; 445(1):36-45. PubMed ID: 16364233
    [Abstract] [Full Text] [Related]

  • 15. The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
    Smith KA, Pease RJ, Avery CA, Brown JM, Adamson PJ, Cooke EJ, Neergaard-Petersen S, Cordell PA, Ariëns RA, Fishwick CW, Philippou H, Grant PJ.
    Blood; 2013 Mar 14; 121(11):2117-26. PubMed ID: 23303819
    [Abstract] [Full Text] [Related]

  • 16. Interaction of factor XIII subunits.
    Katona E, Pénzes K, Csapó A, Fazakas F, Udvardy ML, Bagoly Z, Orosz ZZ, Muszbek L.
    Blood; 2014 Mar 13; 123(11):1757-63. PubMed ID: 24408323
    [Abstract] [Full Text] [Related]

  • 17. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE, Dobson JV, Greenberg CS.
    Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839
    [Abstract] [Full Text] [Related]

  • 18. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
    Lewis KB, Teller DC, Fry J, Lasser GW, Bishop PD.
    Biochemistry; 1997 Feb 04; 36(5):995-1002. PubMed ID: 9033388
    [Abstract] [Full Text] [Related]

  • 19. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ, Minkema J, Bouma BN, Jansen JW.
    Blood Coagul Fibrinolysis; 1993 Dec 04; 4(6):869-75. PubMed ID: 7511944
    [Abstract] [Full Text] [Related]

  • 20. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA, Goldsberry WN, Zink SE, Lamb KN, Simmons KE, Riposo CM, Anokhin BA, Maurer MC.
    Biochim Biophys Acta Proteins Proteom; 2017 Oct 04; 1865(10):1246-1254. PubMed ID: 28687225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.